4DMedical (ASX:4DX) reported Friday fiscal first-half loss of AU$0.259 per share, widening from a loss of AU$0.025 a year earlier.
Revenue for the six months ended Dec. 31, 2025, was AU$2.9 million, compared with AU$2.9 million a year earlier. Analysts surveyed by FactSet expected AU$3 million.
The board continues to not recommend or declare a dividend.